Rocuronium Bromide (Cantrell Drug Company)
Welcome to the PulseAid listing for the Rocuronium Bromide drug offered from Cantrell Drug Company. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cantrell Drug Company |
NON-PROPRIETARY NAME: | Rocuronium Bromide |
SUBSTANCE NAME: | ROCURONIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2015-01-29 |
END MARKETING DATE: | 0000-00-00 |
Rocuronium Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Rocuronium Bromide from Cantrell Drug Company |
LABELER NAME: | Cantrell Drug Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2015-01-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52533-064_70bb36c7-c914-4e1e-936d-55a509561894 |
PRODUCT NDC: | 52533-064 |
APPLICATION NUMBER: | |
Other ROCURONIUM BROMIDE Pharmaceutical Manufacturers / Labelers: